Patient Note — 245897
progress_notes_245897_1_deid.txt
Demographics & Encounter
Patient ID245897 (PHI redacted)
Age / Gender36 / Male
Date of Service2026-01-19
ProviderNone
FacilityPOTOMAC UROLOGY CENTER - Manassas
PayerBind Benefits INC
Reason1. Coloplast webinar
Diagnoses
N52.9
Erectile dysfunction, unspecified erectile dysfunction type
Medications
Rosuvastatin Calcium Tadalafil Zepbound(Tirzepatide-Weight Management) Medication List reviewed and reconciled with the patientVitals
RR
16.0
HR
95.0
BP
114/72
BMI
29.29
WEIGHT
210 lbs
HEIGHT_IN
71.0
Clinical Summary (HPI)
Erectile Dysfunction screening: 1/19/2026 FU ED Erections 7/10 Good libido Took tadalafil 5 daily with benefit in the past ================================ The patient's previous work-up history is listed below: IPSS: 0 (12/11/24) IIEF: 12 (12/11/24) HgbA1c: WNL Nov'24, no history of DM.
Raw Note (de-identified preview)
4/16/26, 12:47 AM Print Preview
[PATIENT_NAME] DOB: [DOB] (36 yo M) Acc No. [ACCOUNT_ID] DOS: 01/19/2026
[PATIENT_NAME]
36 Y old Male, DOB: [DOB]
Account: [ACCOUNT_ID]: [PHONE] [ADDRESS]
Home: [PHONE]
Guarantor: [GUARANTOR_NAME] Insurance: Bind Benefits INC
PCP: [PROVIDER_NAME] Referring: [PROVIDER_NAME]
Appointment Facility: POTOMAC UROLOGY CENTER - Manassas
01/19/2026 FU-SameDay: [PROVIDER_NAME], MD
Reason for Appointment
1. Coloplast webinar
History of Present Illness
Erectile Dysfunction screening:
1/19/2026
FU ED
Erections 7/10
Good libido
Took tadalafil 5 daily with benefit in the past
================================
The patient's previous work-up history is listed below:
IPSS: 0 (12/11/24)
IIEF: 12 (12/11/24)
HgbA1c: WNL Nov'24, no history of DM.
Current Medications
Taking
Rosuvastatin Calcium 20 MG Tablet 1 tablet Orally Once a day
Tadalafil 5 MG Tablet 1 tablet Orally Once a day
Zepbound(Tirzepatide-Weight Management) 10 MG/0.5ML Solution Auto-injector Subcutaneous
Medication List reviewed and reconciled with the patient
Past Medical History
High Cholesterol.
Screening
Allergies
N.K.D.A.
Review of Systems
11 system Review of Systems completed in the chart and all pertinent positives and negatives reviewed with the
patient...fp.
Vital Signs
RR: 16, HR: 95, BP: 114/72 mm Hg, Ht: 71, Wt: 210 lbs, BMI: 29.29 Index.
Progress Note: [PROVIDER_NAME], MD 01/19/2026
Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com)
Generated for Printing/Faxing/eTransmitting on: 04/16/2026 03:47 AM EDT
1/3
4/16/26, 12:47 AM Print Preview
[PATIENT_NAME] DOB: [DOB] (36 yo M) Acc No. [ACCOUNT_ID] DOS: 01/19/2026
Physical Examination
GENITOURINARY - MALE:
Penis: normal, uncircumcised.
Assessments
1.Erectile dysfunction, unspecified erectile dysfunction type - N52.9 (Primary)
Treatment
1.Erectile dysfunction, unspecified erectile dysfunction type
Start Tadalafil Tablet, 5 MG, 1 tablet, Orally, Once a day, 90 days, 90 Tablet, Refills 3
LAB: TESTOSTERONE
Notes:
Trial of daily and on demand Tadalafil 5 mg.
We discussed the common side effects including but not limited to headache, flushing, syncope, vision changes, nausea,
myalgias, dyspepsia, nasal congestion.
Discussed penile doppler, benefits including the diagnosis of the cause of his erectile dysfunction, identification of any
curvature or plaque, and the efficacy of penile injection therapy. Discussed injection of trimix, and the risks associated,
including but not limited to priapism and hematoma, as well as penile curvature with injections over time. The patient
voices understanding and they agree to proceed.
Check T level
Visit Codes
[ZIP] Office Visit, Est Pt., Level 4.
Electronically signed by [PROVIDER_NAME] MD on 01/19/2026 at 05:18 PM EST
Sign off status: Completed
[FACILITY]
[ADDRESS]
STE 220
MANASSAS, VA [ZIP]
Progress Note: [PROVIDER_NAME], MD 01/19/2026
Note generated by eClinicalWorks EMR/PM Software (www.eClinicalWorks.com)
Generated for Printing/Faxing/eTransmitting on: 04/16